Expleo Solutions Limited

EXPLEOSOLDeep value region

A 6-pillar fundamental profile. Each pillar scored 0–10.

7.1/10 composite
Prism for EXPLEOSOL.NS: composite 7.1 of 10, verdict Deep value regionPULSEQUALITYMOATSAFETYGROWTHVALUEBelow cohort range7.27.06.26.29.7

Pulse

· Neutral

Pulse data unavailable; neutral placeholder

Pulse tracks recent momentum in price, analyst revisions, and news sentiment. Higher means more positive near-term tailwinds.

Quality

7.2 · Moderate

Piotroski 7/9, ROCE 20.8%

Quality captures profitability, return on capital, and earnings consistency. Higher means a better business.

Moat

7.0 · Moderate

Moderate moat

Moat estimates durable competitive advantages — brand, scale, switching costs. Higher means more defensible.

Safety

6.2 · Moderate

D/E 0.01

Safety looks at balance-sheet quality, leverage, and cash generation. Higher means lower financial risk.

Growth

6.2 · Moderate

Rev CAGR 7.0%, EPS CAGR 5.8%

Growth reflects revenue and earnings expansion over recent years. Higher means faster compounding.

Value

9.7 · Notable discount to peers

P/E 10.9x (rev mult 1.22x) vs sector median P/E 27.1x (164 peers)

Value measures how the stock's price compares to its intrinsic worth. Higher means more discount to fair value.

Compare with another stock

Overlay EXPLEOSOL's prism against a peer.

Share this prism

Get the full analysis

Interactive DCF, sensitivity, peer comparison, and AI summary for EXPLEOSOL.

Full analysis →

Model estimate. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.

Expleo Solutions Limited (EXPLEOSOL) Prism — YieldIQ